Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Sunstar Foundation to Invite Papers on Periodontal Diseases
January 28, 2002
- Gov't Panel to Monitor Life-Science-Related Projects by Different Ministries
January 28, 2002
- Eli Lilly, Vertex Select Candidate for Hepatitis C Treatment
January 28, 2002
- Serious ADR due to Topical Ketoprofen Reported
January 28, 2002
- Sanofi-Synthelabo Transfers Rights for Gabitril to Cephalon
January 28, 2002
- Results of Quality Reevaluation Announced for 20 Ingredients, 2 Formulations
January 28, 2002
- Sankyo Identifies Gene that Regulates Lipid Metabolism
January 28, 2002
- Hayashibara Strives to Be the Only 1 Rather Than No. 1
January 28, 2002
- Revisions of Precautions Required for 26 Ingredients
January 28, 2002
- JFMDA Prepares Guide on Handling of Used Medical Devices
January 28, 2002
- REGULATORY NEWS IN BRIEF
January 28, 2002
- RIKEN Invites Companies to Collaborate in Gene Polymorphism Analysis
January 28, 2002
- Kitasato Univ. Hospital Upgrades Immediate PMS System
January 28, 2002
- NanoCarrier Contracts with GSK for DDS
January 28, 2002
- Tsuruha: Sales Up 19.8%, Profits Up 27% in Semi-annual Results
January 28, 2002
- Theme for 2002 Baelz Prize Decided
January 28, 2002
- Kokuho Chuokai Welcomes On-line Applications for Reimbursement
January 28, 2002
- Switch to Marketing Approval to Increase Efficiency: FPMAJ President
January 28, 2002
- Link Staff Sets Up New Firm to Support Hospitals M&As
January 28, 2002
- REGULATORY NEWS IN BRIEF
January 21, 2002
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…